Ticagrelor
Therapeutic Category
- Prevention Of Thrombotic Events
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Ticagrelor, under the brand name of Brilinta, is a p2y12 platelet inhibitor indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (acs) or a history of myocardial infarction (mi). For at least the first 12 months following acs, it is superior to clopidogrel. Brilinta also reduces the rate of stent thrombosis in patients who have been stented for treatment of acs.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Ticagrelor with CAS Number: 274693-27-5 . We are a leading exporter of Ticagrelor with CAS Number: 274693-27-5. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading API manufacturer & supplier of Ticagrelor with CAS Number: 274693-27-5 . This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File ( DMF ). Our manufacturing plant at Surat,India has accreditation by US-FDA, EDQM, EMA, ANVISA, KFDA, MOH-IRAN, Health Canada & Russian Authorities.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.